The MEK/ERK Pathway Acts Upstream of NFκB1 (p50) Homodimer Activity and Bcl-2 Expression in a Murine B-Cell Lymphoma Cell LineJohn F. Kurland, Raymond E. Meyn(The University of Texas MD Anderson Cancer Center)Journal of Biological ChemistryAugust 1, 200310.1074/jbc.m212919200Cited by 69SaveCiteExport RISWatch citationsRelated PapersMK-8776, a novel chk1 kinase inhibitor, radiosensitizes p53-defective human tumor cells|Oncotarget|2016|37